Tiefenbacher Group Renovation Of Headquarters In Hamburg
Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.
Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate
Tiefenbacher Group awarded the EcoVadis Silver Medal!
Tiefenbacher Group on awareness for rare disease day
Tiefenbacher Group Renovation of our Headquarters
Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide
New Websites Online
Successful Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority
As the allergy season is starting, we at TIEFENBACHER PHARMACEUTICALS are thrilled to announce that we have successfully prepared the launch of the antihistamine Bilastine for a market entry as Over-the-counter (OTC) medicine in Germany.